A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Halozyme Therapeutics Inc’s current trading price is -14.89% away from its 52-week high, while its distance from the 52-week low is 68.50%. The stock’s
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded an increase of 33.39%. However, over
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 45.70%.However, over the last six months,
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Halozyme Therapeutics Inc.’s current trading price is -7.79% away from its 52-week high, while its distance from the 52-week low is 84.07%. The stock’s price
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 52.06% since the start of this calendar year. Looking back over
In terms of market performance, Halozyme Therapeutics Inc. had a fairly even. The highest value for the stock in the past year was $65.53 on 08/29/24, and the lowest value was recorded at $32.83 on 10/25/23. 52-week price history of HALO Stock Studying a stock’s
All rights reserved © 2024, Powered By Smart TechOne
